Clinical medication guidance for hypertension personalization through pharmacogenomic research and analysis
{{output}}
Objective: We investigated the distribution of polymorphisms in five hypertension-related drug-target genes including cytochrome P450 2C9*3 (CYP2C9 *3), angiotensin II receptor type 1(AGTR1) (1166 A>C), cytochrome P450 2D6 * 10 (... ...
